Cost-effectiveness of cefepime + netilmicin or ceftazidime + amikacin or meropenem monotherapy in febrile neutropenic children with malignancy in Turkey

Journal of Chemotherapy

Volumn 13, Issue 3, 2001, Pages 281-287

  Agaoglu, L ^a   Devecioglu, O ^a   Anak, S ^a   Karakas, Z ^a   Yalman, N ^a   Biner, B ^a   Eryilmaz, E ^a   Goksan, B ^a   Unuvar, A ^a   Agirbasli, H ^a   Can, M ^a   Bilgen, H ^a   Gedikoglu, G ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

Author keywords

Amikacin; Cefepime; Ceftazidime; Febrile neutropenia; Meropenem; Netilmicin; Neutropenia; Pharmacoeconomics

Indexed keywords

AMIKACIN; CEFEPIME; CEFTAZIDIME; MEROPENEM; NETILMICIN;

ADOLESCENT; ANTIBIOTIC THERAPY; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIUM ISOLATION; BLOOD CULTURE; CHILD; COST EFFECTIVENESS ANALYSIS; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; FEBRILE NEUTROPENIA; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; TURKEY (REPUBLIC);

EID: 0034973022     PISSN: 1120009X     EISSN: None     Source Type: Journal    
DOI: 10.1179/joc.2001.13.3.281     Document Type: Article

References (15)

1. Empirical therapy and prevention of infection in immunocompromised host
2. Antibiotic therapy for Gram-negative bacteremia
3. Management of fever in patients with cancer and treatment - Induced neutropenia
4. Monotherapy for fever and neutropenia in cancer patients: A randomized comparison of ceftazidime versus imipenem
5. Equivalent efficacies of meropenem and ceftazidime as empirical monotherapy of febrile neutropenic patients
6. Cefepime as empirical monotherapy in febrile patients with hematological malignancies and neutropenia: A randomized, single-center phase II trial
7. Meropenem versus ceftazidime as empirical monotherapy for febrile neutropenic cancer patients
8. Ceftazidime combined with a short or long course of amikacin for empirical therapy of Gram-negative bacteremia in cancer patients with granulocytopenia
9. Improved prognosis for granulocytopenic patients with Gram-negative bacteremia
10. A comparative study of imipenem versus piperacillin plus gentamicin in the initial management of febrile neutropenic patients with haematological malignancies
11. Ceftazidime versus imipenem-cilastatin as initial monotherapy for febrile neutropenic patients
12. A randomized trial comparing ceftazidime alone with combination antibiotic therapy in cancer patients with fever and neutropenia
13. Monotherapy with meropenem versus combination therapy with ceftazidime plus amikacin as empiric therapy for fever in granulocytopenic patients with cancer
14. The design, analysis and reporting of clinical trials on the empirical antibiotic management of the neutropenic patient
15. Randomized prospective study comparing cost-effectiveness teicoplanin and vancomycin as second-line empiric therapy infection in neutropenic patients